ClinicalTrials.Veeva

Menu

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

A

Assiut University

Status

Begins enrollment in 1 month

Conditions

Warts

Study type

Observational

Funder types

Other

Identifiers

NCT06973473
Treatment of common warts

Details and patient eligibility

About

To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.

Full description

Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with common warts diagnosed clinically and by dermoscopy.
  • Patients older than 18years old.

Exclusion criteria

  • Pregnancy and lactation.
  • Immunosuppression or being under any kind of treatment causing
  • absolute or relative immunosuppression.
  • Patients with chronic systemic diseases.
  • All cases of bleeding tendency or using anticoagulants.
  • Concurrent use of systemic or topical treatments of warts in the last 4 weeks.

Trial contacts and locations

0

Loading...

Central trial contact

Eman Fathy Ahmed Lecturer of Dermatology, Venereology and Andrology Faculty of

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems